Skip to content
value.today

Wize Pharma, Inc.

Formerly OPHTHALIX INC.

Wize Pharma, Inc. is listed today as Big Digital Energy, Inc.: market value, financials and filings are on its company page.

Funding rounds

0 counted as startup funding, 4 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Wize Pharma, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2022$25 MPrivate placement after listing$10 to $50 million

Wize Pharma, Inc.: Private sale, Feb 2022

Investors in this round

1 investor had bought by the notice of Mar 1, 2022: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$25 M of $25 M offered
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities, securities to be acquired by exercising them, other: Common Stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Hetal Majithia · Executive Officer
  • Liam Daniel Wilson · Executive Officer
  • Manning Edward James · Executive Officer, Director
  • Nicholas Jeremy Hughes-Jones · Executive Officer
  • Gregory Edward Martin · Director
  • Michael Forrest Hughes · Director
  • Yossi Edward Keret · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by James Edward Manning, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 1, 2022. Read the notice at the SEC.

optionsSEC
Mar 2021$3 MPrivate placement after listing$2 to $10 million

Wize Pharma, Inc.: Private sale, Mar 2021

Investors in this round

4 investors had bought by the notice of Mar 23, 2021: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Liam Wilson · Executive Officer
  • Manning James · Executive Officer, Director
  • Or Eisenberg · Executive Officer
  • Greg Martin · Director
  • Michael Hughes · Director
  • Yossi Keret · Director
  • Yossi Keret · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On a merger: “Offering was made in connection with the Bid Implementation Agreement between the Issuer and Cosmos Capital Limited, dated December 30, 2020, as amended”

Signed by Or Eisenberg, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 23, 2021. Read the notice at the SEC.

equitySEC
Feb 2020$8 MPrivate placement after listing$2 to $10 million

Wize Pharma, Inc.: Private sale, Feb 2020

Investors in this round

9 investors had bought by the notice of Mar 4, 2020: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $8 M offered
Smallest investment taken
$52,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Noam Danenberg · Executive Officer
  • Or Eisenberg · Executive Officer
  • Franck Amouyal · Director
  • Jospeh Zarzewsky · Director
  • Mark Sieczkarek · Director
  • Michael Belkin · Director
  • Yossi Keret · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Or Eisenberg, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 4, 2020. Read the notice at the SEC.

equitySEC
Oct 2018$4 MPrivate placement after listing$2 to $10 million

Wize Pharma, Inc.: Private sale, Oct 2018

Investors in this round

18 investors had bought by the notice of Nov 7, 2018: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$292,000
Finders' fees
$89,000
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Noam Danenberg · Executive Officer · Chief Operating Officer
  • Or Eisenberg · Executive Officer · Acting Chief Executive Officer, Chief Financial Officer, Treasurer and Secretary
  • Franck Amouyal · Director
  • Joseph Zarzewsky · Director
  • Michael Belkin · Director
  • Ron Mayron · Director · Chairman
  • Yossi Keret · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Fordham Financial Management, Inc. (CRD 20996) · New York, New YorkSold in AK, AL, CA, CO, CT, FL, IL, KS, LA, MA, MD, MN, NC, NJ, NY, OR, TX, WA, WI, and outside the US

Signed by Or Eisenberg, Ceo. Source: SEC Form D, newest notice filed Nov 7, 2018. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • As the listed company Big Digital Energy, Inc., its revenue in fiscal 2025 came from these product and service lines: Digital colocation revenue $26.08 million (66%), Energy management revenue $11.80 million (30%), Digital assets mining revenue $1.88 million (5%).

    Annual report (SEC XBRL) · Dec 2025

  • Wize Pharma, Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2022).

    SEC Form D · Mar 2022

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Mar 2022

Products and services#

No products or services of Wize Pharma, Inc. are on record.

Investors#

No investor of Wize Pharma, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete.

Largest shareholders today

Institutions holding Big Digital Energy, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Wize Pharma, Inc.
NameRoleNamed in
Hetal MajithiaExecutive officerMar 2022
Liam Daniel WilsonExecutive officerMar 2022
Manning Edward JamesExecutive officerMar 2022
Nicholas Jeremy Hughes-JonesExecutive officerMar 2022
Liam WilsonExecutive officerMar 2021
Manning JamesExecutive officerMar 2021
Or EisenbergExecutive officerMar 2021
Noam DanenbergExecutive officerMar 2020
Gregory Edward MartinDirectorMar 2022
Manning Edward JamesDirectorMar 2022
Michael Forrest HughesDirectorMar 2022
Yossi Edward KeretDirectorMar 2022
Greg MartinDirectorMar 2021
Manning JamesDirectorMar 2021
Michael HughesDirectorMar 2021
Yossi KeretDirectorMar 2021
Franck AmouyalDirectorMar 2020
Jospeh ZarzewskyDirectorMar 2020
Mark SieczkarekDirectorMar 2020
Michael BelkinDirectorMar 2020
Joseph ZarzewskyDirectorNov 2018
Ron MayronChairmanNov 2018

Went public since 2014. Its SEC number is that of a company listed on a stock exchange.